1
328
G. Sengle et al. / Bioorg. Med. Chem. 8 (2000) 1317±1329
LRMS (FAB) m/e for C H N O PS (M+H)+,
calcd 603, found 603.
incubated in 1.0 mL 80% acetic acid for 45 min at
ꢀ
20
24
6
10
2
23 C. Excess acetic acid was evaporated in vacuo, the
product suspended in 1.0 mL water and then dried in
vacuo for 20 h. Final puri®cation was achieved by dis-
solving the colourless powder in 2.0 mL buer A (100
mM triethylammonium acetate, pH 7.0) and pre-
parative reversed phase HPLC under the following
conditions: 0±15 min: 85% buer A (100 mM triethy-
lammonium acetate, pH 7.0), 15% buer B (100 mM
Biotin-Cys-GMPS-primed RNA (2b). A 10 mM solution
of thiopyridine-activated biotinylated cysteine 10 in
1
3
0% DMF/50 mM TRIS (pH 7.4) was incubated with
3 mM GMPS primed P labeled 94mer RNA (TRIS
32
buer: 50 mM TRIS, 5 mM MgCl , 250 mM NaCl).
2
The amount of disul®de formation was determined as
quantitative by measuring the UV-absorbance of the
leaving-group thiopyridine at 343 nm after 30 min. The
reacted mixture RNA was precipitated, redesolved in
streptavidin-binding buer and added to column con-
taining 250 mL streptavidin-agarose. After an additional
triethylammonium acetate pH 7.0 in 80% CH CN).
3
Combined fractions were lyophilized in vacuo to yield
+
24.2 mg of a colourless powder (24%). MS (ESI ): m/e
calcd for C H O N P: 463.3, found: 463.3 MH;
16
26
8
6
HPLC (analytical): 10.69 min (7.98 min for triiso-
butyrylguanosine); UV (H O): lmax=252.2 nm, 272 nm
(shoulder).
30 min, the unbound RNA is washed o the column
2
with TRIS buer. Approximately 70% of the RNA
remained bound to streptavidine-agarose could be
detected by scintillation counting. This result implies,
that about 70% of the 94mer RNA was primed with
GMPS during in vitro transcription.
Initiator nucleotide (4a). 24.2 mg (52.4 mmol) amino-
hexyl-guanosine-5 -monophosphate 17 and 194 mg (340
0
mmol) sulfosuccinimidyl-(biotinamido)-ethyl-1,3-dithio-
propionate 18 were dissolved in 35 mL 0.02 M KH PO
2
4
ꢀ
Biotin-Cys-S-Py (9). A solution of d-biotin-N-hydroxy-
succinimide ester (0.165 g, 0.484 mmol) in DMF (2 mL)
was added to a solution containing S-(2-thiopyridyl)-l-
cysteine 6 (0.100g, 0.376 mmol), triethylamine (1.04 mL,
pH 8.1 and stirred at 23 C overnight. The solution was
concentrated to 7.7 mL in vacuo and puri®ed by pre-
parative reversed-phase HPLC as described for amino-
hexyl-guanosine-5 -monophosphate. Combined fractions
were lyophylized in vacuo to yield 26.4 mg of a white
0
7
.50 mmol), H O (1 mL), and CH CN (2 mL). The
2
3
resulting mixture was stirred for 4 h and then con-
centrated by rotary evaporation to obtain a pale white
solid. Recrystallization from methanol and ether aor-
ded 0.138g (80%) of thiopyridyl-biotin 10 as a white
solid (31 mmol, 50%). HABA-Test (SIGMA): 27.3 mg;
1
H NMR (400 M Hz, D O): d=8.07 (s, 1H), 5.88 (d,
2
J=6 Hz, 1H), 4.82 (m, 1H), 4.55 (m 1H), 4.48 (t, J=4
Hz, 1H), 4.36 (m, 1H), 4.29 (m, 1H), 4.04 (s, 2H), 3.69
(t, J=6.5 Hz, 2H), 3.47 (t, J=6.5 Hz, 2H), 3.36 (m,
1H), 3.07 (t, J=7 Hz, 2H), 2.91 (m, 3H), 2.82 (m, 2H),
2.74 (m, 1H), 2.60 (t, J=6.5 Hz, 2H), 2.29 (t, J=7.75
Hz, 2H), 1.70±1.30 (m, 10H), 1.12 (m, 4H); ); 13C NMR
1
solid. H NMR (500 M Hz, D O:CD OD, 10:90)
3
2
d=8.44±8.43 (m, 1H); 7.87±7.82 (m, 2H); 7.30±7.27 (m,
1H); 4.71 (dd, J=9.1, 4.2 Hz, 1H); 4.54±4.51 (m, 1H);
4.35±4.32 (m, 1H); 3.34 (dd, J=13.0, 4.3 Hz, 1H); 3.25±
3.21 (m, 1H); 3.18 (dd, J=14.0, 9.0 Hz, 1H); 2.94 (dd,
(500 M Hz, D O): d=177.2, 174.2, 165.6, 159.2, 154.3,
2
J=12.8, 5.0 Hz, 1H); 2.73±2.70 (m, 1H); 2.33±2.24 (m,
1
152.3, 137.8, 116.6, 87.2, 84.1 (d, JCP=9 Hz), 73.8, 70.8,
66.6 (d, JCP=5.5 Hz), 65.2 (d, JCP=5 Hz), 62.4, 60.6,
55.8, 40.1, 39.6, 38.2, 37.2, 35.8, 35.4, 33.8, 30.0 (d,
JCP=7 Hz), 28.5, 28.2, 28.0, 26.1, 25.5, 24.9; 31P NMR
3
2
H); 1.76±1.59 (m, 4H); 1.50±1.46 (m, 2H). C NMR
(
100 M Hz, D O:CD OD, 10:90) d=176.6, 173.9, 166.3,
2
3
1
4
60.5, 150.6, 139.6, 123.0, 121.8, 63.4, 61.7, 57.0, 53.1,
1.3, 41.2, 36.5, 29.6. 29.4, 26.8. HRMS (FAB) m/e
(121.5 M Hz, D O): d=� 0.1 (s, 1P); MS (MALDI): m/z
2
+
for C H N O S (M+H) , calcd 457.1038, found
1
calcd for C H O S N P: 853.6, found: 853 MH;
9
8
25
4
4
3
31 50 11
3
4
57.1049.
HPLC (preparative): 17.21 min (10.51 min for amino-
hexyl-guanosine-5 -monophosphate); UV (H O): lmax=
0
252.2 nm, 270 nm (shoulder).
2
0
0.44 mmol) 2 -O, 3 -O, N -triisobutyrylguanosine 15
Aminohexyl-guanosine-5 -monophosphate (17). 220 mg
0 0
2
(
were co-evaporated three times from pyridine, dried in
vacuo over P O , and dissolved in 3.0 mL dry CH CN
Alkylsul®de-primed RNA (4b*). 4a-initiated 94mer
RNA was incubated with the same volume of a solution
containing 200 mM DTT, pH 7.4 overnight at 23 C,
afterwards precipitated by addition of NaOAc/ethanol,
washed several times with 70% ethanol and redissolved
in the required buer.
4
10
3
ꢀ
under argon atmosphere. To this, a solution of 150 mg
0.22 mmol) N-monomethoxytrityl-aminohexyl-cya-
noethyl-N,N-diisopropyl phosphoramidite in 3.0 mL
(
dry CH CN, and, subsequently, 1.9 mL of a 0.47 M
3
solution of tetrazol in pyridine were added under argon
atmosphere. After 20 min, 3.0 mL of 0.1 M I , dissolved
in THF:pyridine:H O (2:2:1 v/v) was added. Excess I2
2
L-Citrullyl-cysteine-tri¯uoroacetate (13). To a solution
a
2
of 1.98 g (5.00 mmol) of the activated ester N -Boc-
was reduced by adding 10.0 mL of a saturated Na S O
3
citrulline-p-nitrophenylester 11 in 10 mL DMF a sus-
pension of 1.82 g (5.00 mmol) S-Tritylcysteine 12 in
20 mL of triethylamin:dimethylformamid (1:1 v/v) was
added dropwise. The solution was stirred at ambient
temperature for 16 h, concentrated in vacuo, and the
product was puri®ed by ¯ash chromatography CHCl3:
2
2
solution, the product extracted with 50.0 mL CH Cl .
2
2
The organic phase was washed with 40 mL of saturated
NaHCO , dried with Na SO , and concentrated in
3
2
4
vacuo. Puri®cation was achieved by ¯ash chromato-
graphy (silica gel 0.063±0.200 mm, CH Cl :CH OH
2
2
3
(95:5 v/v)). The product was dissolved in 0.3 mL ethanol
and incubated overnight in 1.0 mL 33% NH at 55 C.
CH OH (1:9 v/v). The product was dissolved in a
3
mixture of 5 mL of tri¯uoroacidic acid and 5 mL of
ethylmercaptane. After 2 h of stirring, the product was
ꢀ
After removal of excess NH in vacuo the product was
3
3